Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial (Q44168825)

30 November 2017

Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial (English)

1 reference

30 November 2017

0 references

1 reference

4

1 reference

30 November 2017

17

1 reference

30 November 2017

Khalid B Beshir

9

0 references

Robert W Sauerwein

15

object named as

Robert W Sauerwein

1 reference

30 November 2017

Lucy Okell

13

0 references

Chris J Drakeley

3

object named as

Chris J Drakeley

1 reference

30 November 2017

16

Rachel L Hallett

1 reference

30 November 2017

1

Patrick Sawa

1 reference

30 November 2017

5

Collins K Mweresa

1 reference

30 November 2017

2

Seif A Shekalaghe

1 reference

30 November 2017

14

Henk D F H Schallig

1 reference

30 November 2017

6

Amrish Y Baidjoe

1 reference

30 November 2017

10

Rahma U Yussuf

1 reference

30 November 2017

12

Cornelus C Hermsen

1 reference

30 November 2017

Alphaxard Manjurano

7

1 reference

30 November 2017

Reginald A Kavishe

8

1 reference

30 November 2017

Sabah A Omar

11

1 reference

30 November 2017

language of work or name

English

0 references

publication date

6 March 2013

1 reference

Journal of Infectious Diseases

30 November 2017

1 reference

30 November 2017

207

1 reference

30 November 2017

11

1 reference

30 November 2017

1637-1645

1 reference

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study

30 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Artemisinin Resistance in Plasmodium falciparum Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Effects of artemisinin derivatives on malaria transmissibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Chloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

A nationwide survey of the quality of antimalarials in retail outlets in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Artemisinin combination therapy for malaria: beyond good efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Qinghaosu (Artemisinin): The Price of Success

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT077

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIT077

1 reference

30 November 2017

1 reference